openPR Logo
Press release

Cardiovascular Calcification Pipeline Assessment, 2023 Updates | In-depth Insights into the Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, Clinical Trials, and Treatment Outlook | Amgen Inc., Novartis AG, Sanofi SA, GlaxoSmithKline, AstraZeneca PLC,

12-19-2023 06:43 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Cardiovascular Calcification Pipeline Assessment, 2023

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, Cardiovascular Calcification pipeline constitutes 6+ key companies continuously working towards developing 6+ Cardiovascular Calcification treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Cardiovascular Calcification Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Cardiovascular Calcification Market.

The Cardiovascular Calcification Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

Some of the key takeaways from the Cardiovascular Calcification Pipeline Report:
• Companies across the globe are diligently working toward developing novel Cardiovascular Calcification treatment therapies with a considerable amount of success over the years. Cardiovascular Calcification Key players such as - Inositec, Sanofi, Abcentra, Dong-A ST, Sanifit, and others, are developing therapies for the Cardiovascular Calcification treatment
• Cardiovascular Calcification Emerging therapies such as - INS 3001, HMR1766, Orticumab, Evogliptin, SNF472, and others are expected to have a significant impact on the Cardiovascular Calcification market in the coming years.
• placebo-controlled Phase 3 clinical trial will examine the efficacy and safety of SNF472 in patients who have ulcerated calciphylaxis lesions. Patient recruitment is ongoing and the trial is expected to be completed by April 2022
• In February 2020, Sanifit Therapeutics S. A. initiated a Phase 3, Randomized, DoubleBlind, Placebo-Controlled Study to Assess the Efficacy and Safety of SNF472 When Added to Background Care for the Treatment of Calciphylaxis

Cardiovascular Calcification Overview
Cardiovascular Calcification is a process in which mineral deposits formed in vessel walls and heart valve leaflets can lead to tissue stiffening, plaque rupture and heart failure. Several biological processes contribute to cardiovascular calcification, including extracellular vesicle release, matrix remodeling, loss of mineral-deposition inhibition, impaired mineral resorption, oxidative stress, mitochondrial dysfunction, inflammation and stem and progenitor cell programmes.

Get a Free Sample PDF Report to know more about Cardiovascular Calcification Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/cardiovascular-calcification-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Emerging Cardiovascular Calcification Drugs Under Different Phases of Clinical Development Include:
• INS 3001: Inositec
• HMR1766: Sanofi
• INS-3001: Inositec
• Orticumab: Abcentra
• Evogliptin: Dong-A ST
• SNF472: Sanifit
Route of Administration
Cardiovascular Calcification pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Oral
• Parenteral
• Intravitreal
• Subretinal
• Topical.
• Molecule Type

Molecule Type
Products have been categorized under various Molecule types, such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
• Product Type

Cardiovascular Calcification Pipeline Therapeutics Assessment
• Cardiovascular Calcification Assessment by Product Type
• Cardiovascular Calcification By Stage and Product Type
• Cardiovascular Calcification Assessment by Route of Administration
• Cardiovascular Calcification By Stage and Route of Administration
• Cardiovascular Calcification Assessment by Molecule Type
• Cardiovascular Calcification by Stage and Molecule Type

DelveInsight's Cardiovascular Calcification Report covers around 6+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration

Further Cardiovascular Calcification product details are provided in the report. Download the Cardiovascular Calcification pipeline report to learn more about the emerging Cardiovascular Calcification therapies
https://www.delveinsight.com/sample-request/cardiovascular-calcification-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key companies in the Cardiovascular Calcification Therapeutics Market include:
Key companies developing therapies for Cardiovascular Calcification are - Amgen Inc., Novartis AG, Sanofi SA, GlaxoSmithKline, AstraZeneca PLC, Merck & Co., Inc., Eli Lilly and Company, Johnson & Johnson, Pfizer Inc., Boehringer Ingelheim, and others.

Cardiovascular Calcification Pipeline Analysis:
The Cardiovascular Calcification pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Cardiovascular Calcification with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Cardiovascular Calcification Treatment.
• Cardiovascular Calcification key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Cardiovascular Calcification Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Cardiovascular Calcification market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Request for Sample PDF Report for Cardiovascular Calcification Pipeline Assessment and clinical trials
https://www.delveinsight.com/sample-request/cardiovascular-calcification-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Cardiovascular Calcification Pipeline Market Drivers
• Advances in imaging techniques used to diagnose cardiovascular calcification
• Advances in computational tools that can help to identify novel target to treat cardiovascular calcification

Cardiovascular Calcification Pipeline Market Barriers
• Lack of approved therapies and only a few ongoing clinical trials
• Pathogenesis of the disease in not completely understood

Scope of Cardiovascular Calcification Pipeline Drug Insight
• Coverage: Global
• Key Cardiovascular Calcification Companies: Inositec, Sanofi, Abcentra, Dong-A ST, Sanifit, and others
• Key Cardiovascular Calcification Therapies: INS 3001, HMR1766, Orticumab, Evogliptin, SNF472, and others
• Cardiovascular Calcification Therapeutic Assessment: Cardiovascular Calcification current marketed and Cardiovascular Calcification emerging therapies
• Cardiovascular Calcification Market Dynamics: Cardiovascular Calcification market drivers and Cardiovascular Calcification market barriers

Download Sample PDF Report to know more about Cardiovascular Calcification drugs and therapies
https://www.delveinsight.com/sample-request/cardiovascular-calcification-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1 Cardiovascular Calcification Report Introduction
2 Cardiovascular Calcification Executive Summary
3 Cardiovascular Calcification Overview
4 Cardiovascular Calcification- Analytical Perspective In-depth Commercial Assessment
5 Cardiovascular Calcification Pipeline Therapeutics
6 Cardiovascular Calcification Late Stage Products (Phase II/III)
7 Cardiovascular Calcification Mid Stage Products (Phase II)
8 Cardiovascular Calcification Early Stage Products (Phase I)
9 Cardiovascular Calcification Preclinical Stage Products
10 Cardiovascular Calcification Therapeutics Assessment
11 Cardiovascular Calcification Inactive Products
12 Company-University Collaborations (Licensing/Partnering) Analysis
13 Cardiovascular Calcification Key Companies
14 Cardiovascular Calcification Key Products
15 Cardiovascular Calcification Unmet Needs
16 Cardiovascular Calcification Market Drivers and Barriers
17 Cardiovascular Calcification Future Perspectives and Conclusion
18 Cardiovascular Calcification Analyst Views
19 Appendix
20 About DelveInsight
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Related Reports:

Cardiovascular Calcification Market https://www.delveinsight.com/report-store/cardiovascular-calcification-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Cardiovascular Calcification Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),

Cardiovascular Calcification Epidemiology https://www.delveinsight.com/report-store/cardiovascular-calcification-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Cardiovascular Calcification Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Latest Reports:
Ventricular Assist Devices Market https://www.delveinsight.com/report-store/ventricular-assist-devices-vad-market
Ventricular Assist Devices Market By Product Type (Left Ventricular Assist Devices, Right Ventricular Assist Devices, And Biventricular Assist Devices), By Application Type (Bridge-To-Transplant [Btt], Destination Therapy, And Others), By Design Type (Transcutaneous Ventricular Assist Devcies And Implantable Ventricular Assist Devices), By Type Of Flow (Pulsatile Flow And Continous Flow), By End User (Hospital And Clinics, Ambulatory Surgical Centers, And Others), by geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing prevalence of heart failure and cardiovascular diseases due to obesity, age, & unhealthy lifestyles and rising demand for organ transplants due to increasing prevalence of chronic ailments such as hypertension, diabetes, and others

B-cell Non-hodgkin Lymphoma Market https://www.delveinsight.com/report-store/b-cell-non-hodgkin-lymphoma-market
DelveInsight's "B-Cell Non-Hodgkin Lymphoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the B-Cell Non-Hodgkin Lymphoma, historical and forecasted epidemiology as well as the B-Cell Non-Hodgkin Lymphoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Systemic Sclerosis Market
https://www.delveinsight.com/report-store/systemic-sclerosis-market
DelveInsight's "Systemic Sclerosis Market Insights, Epidemiology, and Market Forecast - 2032" comprehensively analyzes Systemic Sclerosis. The report includes a detailed examination of the historical and projected epidemiology data that includes diagnosed prevalent cases of Systemic Sclerosis segmented by gender-specific, age-specific, and type-specific cases.

Resorbable Vascular Scaffold Market
https://www.delveinsight.com/report-store/resorbable-vascular-scaffolds-market
"DelveInsight's 'Resorbable Vascular Scaffolds Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Resorbable Vascular Scaffolds and the historical and forecasted Resorbable Vascular Scaffolds market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Vascular Stents Market
https://www.delveinsight.com/report-store/vascular-stents-market
Vascular Stents Market By Product Type (Coronary Stents, Peripheral Stents [Carotid Stents, Iliac Stents, Femoral Stents, Femoral Stents, Other], Evar Stent Grafts [Abdominal Aortic Aneurysm Stents, Thoracic Aortic Aneurysm Stents]), By Type (Bare-Metal Stents, Drug-Eluting Stents), By Material (Metal And Polymer), By Mode Of Delivery (Balloon-Expandable Stents And Self Expandable Stents), By End-User (Hospitals And Ambulatory Surgical Centers), by geography, is expected to grow at a noteworthy CAGR forecast till 2028 owing to rising burden of vascular diseases across the globe and increasing preferences of minimally invasive surgeries among the patient population.

Bladder Scanners Market
https://www.delveinsight.com/report-store/bladder-scanners-market
"DelveInsight's 'Bladder Scanners Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Bladder Scanners and the historical and forecasted Bladder Scanners market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Vein Illumination Devices Market
https://www.delveinsight.com/report-store/vein-illumination-devices-market
"DelveInsight's 'Vein Illumination Devices Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Vein Illumination Devices and the historical and forecasted Vein Illumination Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Ventilator Market
https://www.delveinsight.com/report-store/ventilators-market
Ventilators Market By Mobility (Intensive Care Ventilators, Portable/Transportable Ventilators), By Type (Adult/Pediatric Ventilators, Neonatal/Infant Ventilators), By Interface (Invasive Ventilation, Non-Invasive Ventilation), By End-User (Hospitals, Home Care, Ambulatory Surgical Centers, Others), By Geography is expected to grow at a steady CAGR forecast till 2028 owing to launch of advanced devices and increasing prevalence of respiratory diseases such as COPD.

Vascular Graft Devices Market
https://www.delveinsight.com/report-store/vascular-grafts-market
Vascular Graft Devices Market By Product Type (Endovascular Grafts [Abdominal And Thoracic], Access Grafts, Peripheral Grafts, And Others), By Type (Knitted, Woven, And Others), By Material (Synthetic[ Polytetrafluoroethylene [PTFE], Polyester, Polyurethane], Biological, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Others), by geography is expected to register commendable revenue growth at a steady CAGR forecast till 2028 owing to increasing prevalence of cardiovascular diseases such as aortic aneurysms and peripheral artery disease and growing patient for kidney dialysis.

Patient Monitoring Devices Market
https://www.delveinsight.com/report-store/patient-monitoring-devices-market
Patient Monitoring Devices Market By Type Of Devices (Neuromonitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Hemodynamic Monitoring Devices, Blood Glucose Monitoring Systems, And Others), By Application (Cardiology, Neurology, Respiratory, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings, And Others), by geography, is anticipated to grow at a significant CAGR till 2028 owing to the growing prevalence of various chronic disorders and integration of advanced technology in the products.

Symptomatic Partial-thickness Rotator Cuff Tears Market
https://www.delveinsight.com/report-store/symptomatic-partial-thickness-rotator-cuff-tears-market
DelveInsight's "Symptomatic Partial-thickness Rotator Cuff Tears Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Symptomatic Partial-thickness Rotator Cuff Tears, historical and forecasted epidemiology as well as the Symptomatic Partial-thickness Rotator Cuff Tears market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Zika Virus Market
https://www.delveinsight.com/report-store/zika-virus-market
DelveInsight's "Zika Virus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Zika Virus, historical and forecasted epidemiology as well as the Zika Virus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Contact Us:
Gaurav Bora
gbora@delveinsight.com
+1(919)321-6187
www.delveinsight.com/consulting

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cardiovascular Calcification Pipeline Assessment, 2023 Updates | In-depth Insights into the Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, Clinical Trials, and Treatment Outlook | Amgen Inc., Novartis AG, Sanofi SA, GlaxoSmithKline, AstraZeneca PLC, here

News-ID: 3332804 • Views:

More Releases from DelveInsight Business Research

Lymphangioleiomyomatosis Market to Witness Promising Upswing by 2032, DelveInsight Forecasts
Lymphangioleiomyomatosis Market to Witness Promising Upswing by 2032, DelveInsig …
DelveInsight's "Lymphangioleiomyomatosis Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Lymphangioleiomyomatosis, historical and forecasted epidemiology as well as the Lymphangioleiomyomatosis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. The latest healthcare forecast report provides an in-depth analysis of Lymphangioleiomyomatosis, offering comprehensive insights into the Lymphangioleiomyomatosis revenue trends, prevalence, and treatment landscape. The report delves into key Lymphangioleiomyomatosis
Progressive Supranuclear Palsy Market Expected to Gain Momentum Through 2034, According to DelveInsight
Progressive Supranuclear Palsy Market Expected to Gain Momentum Through 2034, Ac …
DelveInsight's "Progressive Supranuclear Palsy Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Progressive Supranuclear Palsy, historical and forecasted epidemiology as well as the Progressive Supranuclear Palsy market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. The latest healthcare forecast report provides an in-depth analysis of Progressive Supranuclear Palsy, offering comprehensive insights into the Progressive Supranuclear Palsy revenue trends,
Beta Thalassemia Market Trends Point to Steady Growth Ahead by 2034, DelveInsight Analysis Reveals
Beta Thalassemia Market Trends Point to Steady Growth Ahead by 2034, DelveInsigh …
DelveInsight's "Beta Thalassemia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Beta Thalassemia, historical and forecasted epidemiology as well as the Beta Thalassemia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Beta Thalassemia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Beta Thalassemia Market Forecast https://www.delveinsight.com/sample-request/beta-thalassemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the key facts
Sickle Cell Disease Pipeline 2025: Detailed Clinical Trials and FDA-Approved Therapies Review
Sickle Cell Disease Pipeline 2025: Detailed Clinical Trials and FDA-Approved The …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Sickle Cell Disease pipeline constitutes 55+ key companies continuously working towards developing 60+ Sickle Cell Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Sickle Cell Disease Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase.

All 5 Releases


More Releases for Cardiovascular

Rising Cardiovascular Diseases Drive Demand For Cardiovascular Medical Lasers Dr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Cardiovascular Medical Lasers Market Size By 2025? In recent times, there has been a significant expansion in the market size of cardiovascular medical lasers. Projections indicate a surge from $0.31 billion in 2024 to $0.45 billion in 2025, reflecting a compound annual growth rate (CAGR)
Rising Prevalence Of Cardiovascular Disorders Fuels Growth In The Cardiovascular …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Cardiovascular Devices Market Through 2025? In recent times, there has been a significant expansion in the cardiovascular devices market size. It is expected to surge from $73.14 billion in 2024 to $79.78 billion in 2025, reflecting a compound annual growth rate (CAGR)
Impact Of Increasing Cardiovascular Disease Patients On The Cardiovascular Infor …
The Cardiovascular Information System Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Current Cardiovascular Information System Market Size and Its Estimated Growth Rate? The cardiovascular information system market has seen strong growth in recent years. It will rise from $1.16 billion in 2024
Surge In Cardiovascular Diseases Fuels Growth Of Cardiovascular Digital Solution …
The Cardiovascular Digital Solutions Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Cardiovascular Digital Solutions Market Size During the Forecast Period? The market size for cardiovascular digital solutions has been experiencing robust growth in the past few years. The forecast suggests it
Rising Incidence Of Cardiovascular Diseases Fuels Growth Of The Cardiovascular C …
What combination of drivers is leading to accelerated growth in the cardiovascular clinical trials market? The upward trend in cardiovascular diseases is predicted to propel the cardiovascular clinical trials market's expansion. Cardiovascular disease is a term that encompasses a range of conditions impacting the heart and blood vessels including coronary artery disease, heart failure, and stroke. A rise in cardiovascular diseases can be attributed to multiple factors like inactive lifestyles, poor
Cardiovascular Devices Market - Heart-Centric Innovations: Elevating Cardiovascu …
Newark, New Castle, USA: The "Cardiovascular Devices Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Cardiovascular Devices Market: https://www.growthplusreports.com/report/cardiovascular-devices-market/7791 This latest report researches the industry structure, sales, revenue,